Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs. [electronic resource]
Producer: 20170424Description: 36-43 p. digitalISSN:- 1096-0333
- Animals
- Animals, Newborn
- Antiviral Agents -- pharmacology
- Biomarkers -- blood
- DNA, Viral -- genetics
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Resistance, Viral
- Drug Therapy, Combination
- Ducks
- Flavonoids -- pharmacology
- Guanine -- analogs & derivatives
- Hep G2 Cells
- Hepatitis B Surface Antigens -- blood
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- diagnosis
- Hepatocyte Nuclear Factor 1-alpha -- genetics
- Hepatocyte Nuclear Factor 4 -- genetics
- Host-Pathogen Interactions
- Humans
- RNA, Viral -- biosynthesis
- Time Factors
- Transcription, Genetic -- drug effects
- Transfection
- Viral Load
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.